It is funny,
The answer "why" give zivo another year was not offered.
Currently, the volume continues. The chart setup is primed for a move up. Fundamentally, positive news on Nutriquest testing would be optimal right now. In addition, a launch of the final phase of testing/validation with Zoetis would be ideal albeit YEARS late.
As I said before, Dahl has never learned the power of a strong stock price. Would be ideal for this thing to be moving above .25 and getting the money needed to finish at least 1 vertical. Fundamental and technical coming together for positive movement.
But not holding my breath. Dahl routinely throws water on everything and never produces on any reasonable timetable.
Amigo Mike